nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—SLC22A8—choroid plexus—intracranial aneurysm	0.0938	0.177	CbGeAlD
Methotrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0493	0.105	CbGpPWpGaD
Methotrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0419	0.089	CbGpPWpGaD
Methotrexate—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0326	0.0693	CbGpPWpGaD
Methotrexate—MTHFR—artery—intracranial aneurysm	0.0285	0.0538	CbGeAlD
Methotrexate—FOLR1—Folate Metabolism—CCL2—intracranial aneurysm	0.0239	0.0509	CbGpPWpGaD
Methotrexate—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0197	0.0418	CbGpPWpGaD
Methotrexate—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0192	0.0409	CbGpPWpGaD
Methotrexate—AOX1—Effects of Nitric Oxide—NOS3—intracranial aneurysm	0.0179	0.0381	CbGpPWpGaD
Methotrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0175	0.0372	CbGpPWpGaD
Methotrexate—ATIC—brainstem—intracranial aneurysm	0.0163	0.0308	CbGeAlD
Methotrexate—FOLR1—cerebellum—intracranial aneurysm	0.0142	0.0269	CbGeAlD
Methotrexate—GGH—medulla oblongata—intracranial aneurysm	0.0134	0.0253	CbGeAlD
Methotrexate—DHFR—E2F transcription factor network—RBBP8—intracranial aneurysm	0.0126	0.0269	CbGpPWpGaD
Methotrexate—SLC19A1—cerebellum—intracranial aneurysm	0.0125	0.0236	CbGeAlD
Methotrexate—GGH—midbrain—intracranial aneurysm	0.0122	0.0231	CbGeAlD
Methotrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—intracranial aneurysm	0.0118	0.0251	CbGpPWpGaD
Methotrexate—FPGS—medulla oblongata—intracranial aneurysm	0.0118	0.0222	CbGeAlD
Methotrexate—FOLR1—brain—intracranial aneurysm	0.0116	0.0219	CbGeAlD
Methotrexate—TYMS—E2F transcription factor network—RBBP8—intracranial aneurysm	0.011	0.0234	CbGpPWpGaD
Methotrexate—ATIC—midbrain—intracranial aneurysm	0.0104	0.0197	CbGeAlD
Methotrexate—SLC19A1—brain—intracranial aneurysm	0.0101	0.0192	CbGeAlD
Methotrexate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0099	0.021	CbGpPWpGaD
Methotrexate—SLC46A1—cerebellum—intracranial aneurysm	0.00962	0.0182	CbGeAlD
Methotrexate—SLC19A1—Folate Metabolism—CCL2—intracranial aneurysm	0.00953	0.0202	CbGpPWpGaD
Methotrexate—GGH—cerebellum—intracranial aneurysm	0.00947	0.0179	CbGeAlD
Methotrexate—SLCO1C1—midbrain—intracranial aneurysm	0.00865	0.0163	CbGeAlD
Methotrexate—SLCO3A1—medulla oblongata—intracranial aneurysm	0.00832	0.0157	CbGeAlD
Methotrexate—FPGS—cerebellum—intracranial aneurysm	0.00832	0.0157	CbGeAlD
Methotrexate—DHFR—Metabolism of nitric oxide—NOS3—intracranial aneurysm	0.00817	0.0174	CbGpPWpGaD
Methotrexate—ATIC—cerebellum—intracranial aneurysm	0.00805	0.0152	CbGeAlD
Methotrexate—SLC46A1—brain—intracranial aneurysm	0.00781	0.0148	CbGeAlD
Methotrexate—GGH—brain—intracranial aneurysm	0.00769	0.0145	CbGeAlD
Methotrexate—DHFR—medulla oblongata—intracranial aneurysm	0.00764	0.0144	CbGeAlD
Methotrexate—SLCO3A1—midbrain—intracranial aneurysm	0.00761	0.0144	CbGeAlD
Methotrexate—PGD—medulla oblongata—intracranial aneurysm	0.00735	0.0139	CbGeAlD
Methotrexate—TYMS—midbrain—intracranial aneurysm	0.00706	0.0133	CbGeAlD
Methotrexate—DHFR—midbrain—intracranial aneurysm	0.00699	0.0132	CbGeAlD
Methotrexate—SLC16A1—medulla oblongata—intracranial aneurysm	0.00686	0.013	CbGeAlD
Methotrexate—FPGS—brain—intracranial aneurysm	0.00676	0.0128	CbGeAlD
Methotrexate—PGD—midbrain—intracranial aneurysm	0.00672	0.0127	CbGeAlD
Methotrexate—ATIC—brain—intracranial aneurysm	0.00654	0.0123	CbGeAlD
Methotrexate—SLC46A1—Folate Metabolism—CCL2—intracranial aneurysm	0.00631	0.0134	CbGpPWpGaD
Methotrexate—ABCC10—medulla oblongata—intracranial aneurysm	0.0063	0.0119	CbGeAlD
Methotrexate—SLC16A1—midbrain—intracranial aneurysm	0.00627	0.0118	CbGeAlD
Methotrexate—MTHFR—cerebellum—intracranial aneurysm	0.00598	0.0113	CbGeAlD
Methotrexate—SLCO3A1—cerebellum—intracranial aneurysm	0.00589	0.0111	CbGeAlD
Methotrexate—SLC19A1—Disease—SLC25A16—intracranial aneurysm	0.00583	0.0124	CbGpPWpGaD
Methotrexate—ABCC10—midbrain—intracranial aneurysm	0.00576	0.0109	CbGeAlD
Methotrexate—TYMS—cerebellum—intracranial aneurysm	0.00546	0.0103	CbGeAlD
Methotrexate—SLCO1C1—brain—intracranial aneurysm	0.00543	0.0103	CbGeAlD
Methotrexate—SLCO1A2—medulla oblongata—intracranial aneurysm	0.00543	0.0103	CbGeAlD
Methotrexate—DHFR—cerebellum—intracranial aneurysm	0.0054	0.0102	CbGeAlD
Methotrexate—PGD—cerebellum—intracranial aneurysm	0.0052	0.00982	CbGeAlD
Methotrexate—SLC22A7—brain—intracranial aneurysm	0.00515	0.00973	CbGeAlD
Methotrexate—SLC22A6—brain—intracranial aneurysm	0.00497	0.0094	CbGeAlD
Methotrexate—SLCO1A2—midbrain—intracranial aneurysm	0.00496	0.00938	CbGeAlD
Methotrexate—FPGS—Disease—SLC25A16—intracranial aneurysm	0.00496	0.0105	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—SLC25A16—intracranial aneurysm	0.00488	0.0104	CbGpPWpGaD
Methotrexate—MTHFR—brain—intracranial aneurysm	0.00486	0.00918	CbGeAlD
Methotrexate—SLC16A1—cerebellum—intracranial aneurysm	0.00485	0.00916	CbGeAlD
Methotrexate—SLCO3A1—brain—intracranial aneurysm	0.00478	0.00903	CbGeAlD
Methotrexate—MTHFR—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.00468	0.00995	CbGpPWpGaD
Methotrexate—AOX1—cerebellum—intracranial aneurysm	0.00458	0.00865	CbGeAlD
Methotrexate—ABCC10—cerebellum—intracranial aneurysm	0.00445	0.00842	CbGeAlD
Methotrexate—TYMS—brain—intracranial aneurysm	0.00443	0.00838	CbGeAlD
Methotrexate—DHFR—brain—intracranial aneurysm	0.00439	0.00829	CbGeAlD
Methotrexate—PGD—NRF2 pathway—AGER—intracranial aneurysm	0.00427	0.00906	CbGpPWpGaD
Methotrexate—PGD—brain—intracranial aneurysm	0.00422	0.00797	CbGeAlD
Methotrexate—FPGS—Metabolism—SLC25A16—intracranial aneurysm	0.00415	0.00882	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—SLC25A16—intracranial aneurysm	0.00415	0.00882	CbGpPWpGaD
Methotrexate—SLC16A1—brain—intracranial aneurysm	0.00394	0.00744	CbGeAlD
Methotrexate—ABCC4—Platelet degranulation—TIMP1—intracranial aneurysm	0.0039	0.00828	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—SLC25A16—intracranial aneurysm	0.00386	0.00821	CbGpPWpGaD
Methotrexate—SLCO1A2—cerebellum—intracranial aneurysm	0.00384	0.00725	CbGeAlD
Methotrexate—MTHFR—Folate Metabolism—CCL2—intracranial aneurysm	0.00381	0.00809	CbGpPWpGaD
Methotrexate—AOX1—brain—intracranial aneurysm	0.00372	0.00702	CbGeAlD
Methotrexate—ABCC4—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00371	0.00789	CbGpPWpGaD
Methotrexate—ABCG2—medulla oblongata—intracranial aneurysm	0.00369	0.00697	CbGeAlD
Methotrexate—ABCC3—brain—intracranial aneurysm	0.00364	0.00687	CbGeAlD
Methotrexate—ABCC10—brain—intracranial aneurysm	0.00362	0.00684	CbGeAlD
Methotrexate—PGD—Disease—SLC25A16—intracranial aneurysm	0.00353	0.00751	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—CCL2—intracranial aneurysm	0.00339	0.00719	CbGpPWpGaD
Methotrexate—ABCG2—midbrain—intracranial aneurysm	0.00337	0.00637	CbGeAlD
Methotrexate—SLC46A1—Metabolism—SLC25A16—intracranial aneurysm	0.00324	0.00687	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—ASAH1—intracranial aneurysm	0.00324	0.00687	CbGpPWpGaD
Methotrexate—ABCC1—cerebellum—intracranial aneurysm	0.00315	0.00595	CbGeAlD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00312	0.00663	CbGpPWpGaD
Methotrexate—SLCO1A2—brain—intracranial aneurysm	0.00312	0.00589	CbGeAlD
Methotrexate—ALB—brain—intracranial aneurysm	0.0031	0.00586	CbGeAlD
Methotrexate—MTHFR—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00303	0.00643	CbGpPWpGaD
Methotrexate—ABCC4—brain—intracranial aneurysm	0.003	0.00567	CbGeAlD
Methotrexate—TYMS—Circadian rythm related genes—CST3—intracranial aneurysm	0.00299	0.00636	CbGpPWpGaD
Methotrexate—SLC22A8—brain—intracranial aneurysm	0.00298	0.00563	CbGeAlD
Methotrexate—PGD—Metabolism—SLC25A16—intracranial aneurysm	0.00296	0.00629	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—ASAH1—intracranial aneurysm	0.00275	0.00585	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—ASAH1—intracranial aneurysm	0.00275	0.00585	CbGpPWpGaD
Methotrexate—ABCG2—cerebellum—intracranial aneurysm	0.00261	0.00493	CbGeAlD
Methotrexate—ABCC1—brain—intracranial aneurysm	0.00256	0.00484	CbGeAlD
Methotrexate—DHFR—Cell Cycle—RBBP8—intracranial aneurysm	0.00254	0.00539	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SLC25A16—intracranial aneurysm	0.00233	0.00495	CbGpPWpGaD
Methotrexate—AOX1—Disease—SLC25A16—intracranial aneurysm	0.00228	0.00484	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—CST3—intracranial aneurysm	0.00224	0.00475	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—RBBP8—intracranial aneurysm	0.00221	0.0047	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ASAH1—intracranial aneurysm	0.00214	0.00455	CbGpPWpGaD
Methotrexate—ABCG2—brain—intracranial aneurysm	0.00212	0.004	CbGeAlD
Methotrexate—DHFR—Disease—SLC25A16—intracranial aneurysm	0.00207	0.0044	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00207	0.00439	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ASAH1—intracranial aneurysm	0.00196	0.00417	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SLC25A16—intracranial aneurysm	0.00195	0.00415	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NCF1—intracranial aneurysm	0.00194	0.00413	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SLC25A16—intracranial aneurysm	0.00191	0.00405	CbGpPWpGaD
Methotrexate—FPGS—Disease—CST3—intracranial aneurysm	0.0019	0.00404	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00186	0.00396	CbGpPWpGaD
Methotrexate—ABCB1—medulla oblongata—intracranial aneurysm	0.00182	0.00344	CbGeAlD
Methotrexate—ABCC3—NRF2 pathway—AGER—intracranial aneurysm	0.00181	0.00384	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—TIMP1—intracranial aneurysm	0.00176	0.00375	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SLC25A16—intracranial aneurysm	0.00173	0.00369	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00173	0.00367	CbGpPWpGaD
Methotrexate—ABCC4—NRF2 pathway—AGER—intracranial aneurysm	0.0017	0.00361	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00168	0.00357	CbGpPWpGaD
Methotrexate—ABCB1—midbrain—intracranial aneurysm	0.00166	0.00314	CbGeAlD
Methotrexate—FPGS—Disease—NCF1—intracranial aneurysm	0.00165	0.00351	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00162	0.00345	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SLC25A16—intracranial aneurysm	0.00158	0.00336	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SLC25A16—intracranial aneurysm	0.00151	0.00322	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CST3—intracranial aneurysm	0.00148	0.00315	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00146	0.0031	CbGpPWpGaD
Methotrexate—ABCC2—NRF2 pathway—AGER—intracranial aneurysm	0.00143	0.00304	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SLC25A16—intracranial aneurysm	0.00139	0.00295	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00139	0.00295	CbGpPWpGaD
Methotrexate—PGD—Disease—CST3—intracranial aneurysm	0.00135	0.00288	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ASAH1—intracranial aneurysm	0.00129	0.00275	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NCF1—intracranial aneurysm	0.00129	0.00274	CbGpPWpGaD
Methotrexate—ABCB1—cerebellum—intracranial aneurysm	0.00129	0.00243	CbGeAlD
Methotrexate—ALB—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.00128	0.00272	CbGpPWpGaD
Methotrexate—ABCC4—Ectoderm Differentiation—CCL2—intracranial aneurysm	0.00127	0.00271	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ASAH1—intracranial aneurysm	0.00126	0.00268	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SLC25A16—intracranial aneurysm	0.00125	0.00266	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TIMP1—intracranial aneurysm	0.0012	0.00254	CbGpPWpGaD
Methotrexate—PGD—Disease—NCF1—intracranial aneurysm	0.00118	0.0025	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SLC25A16—intracranial aneurysm	0.00117	0.00249	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ASAH1—intracranial aneurysm	0.00115	0.00244	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SLC25A16—intracranial aneurysm	0.00109	0.00232	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ASAH1—intracranial aneurysm	0.00105	0.00222	CbGpPWpGaD
Methotrexate—ABCB1—brain—intracranial aneurysm	0.00104	0.00197	CbGeAlD
Methotrexate—ALB—Folate Metabolism—CCL2—intracranial aneurysm	0.00104	0.00221	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ASAH1—intracranial aneurysm	0.001	0.00213	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC25A16—intracranial aneurysm	0.000982	0.00209	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000963	0.00205	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC25A16—intracranial aneurysm	0.000933	0.00198	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ASAH1—intracranial aneurysm	0.00092	0.00195	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CST3—intracranial aneurysm	0.000893	0.0019	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TIMP1—intracranial aneurysm	0.000891	0.00189	CbGpPWpGaD
Methotrexate—AOX1—Disease—CST3—intracranial aneurysm	0.000873	0.00185	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC25A16—intracranial aneurysm	0.000864	0.00184	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ASAH1—intracranial aneurysm	0.00083	0.00176	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.000826	0.00176	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NOS3—intracranial aneurysm	0.000806	0.00171	CbGpPWpGaD
Methotrexate—DHFR—Disease—CST3—intracranial aneurysm	0.000794	0.00169	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000793	0.00168	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000782	0.00166	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NCF1—intracranial aneurysm	0.000777	0.00165	CbGpPWpGaD
Methotrexate—AOX1—Disease—NCF1—intracranial aneurysm	0.000759	0.00161	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ASAH1—intracranial aneurysm	0.000723	0.00154	CbGpPWpGaD
Methotrexate—DHFR—Disease—NCF1—intracranial aneurysm	0.00069	0.00147	CbGpPWpGaD
Methotrexate—FPGS—Disease—NOS3—intracranial aneurysm	0.000685	0.00146	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—NOS3—intracranial aneurysm	0.000675	0.00143	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ASAH1—intracranial aneurysm	0.00065	0.00138	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ASAH1—intracranial aneurysm	0.000618	0.00131	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—NOS3—intracranial aneurysm	0.000574	0.00122	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—NOS3—intracranial aneurysm	0.000574	0.00122	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ASAH1—intracranial aneurysm	0.000572	0.00122	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NOS3—intracranial aneurysm	0.000539	0.00114	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS3—intracranial aneurysm	0.000534	0.00113	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC25A16—intracranial aneurysm	0.000533	0.00113	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS3—intracranial aneurysm	0.000488	0.00104	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.000467	0.000992	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CST3—intracranial aneurysm	0.000449	0.000955	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—NOS3—intracranial aneurysm	0.000447	0.00095	CbGpPWpGaD
Methotrexate—PGD—Metabolism—NOS3—intracranial aneurysm	0.000409	0.000869	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TIMP1—intracranial aneurysm	0.000403	0.000857	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS3—intracranial aneurysm	0.000402	0.000853	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NCF1—intracranial aneurysm	0.000391	0.00083	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ASAH1—intracranial aneurysm	0.000353	0.00075	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS3—intracranial aneurysm	0.000322	0.000685	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS3—intracranial aneurysm	0.000315	0.000669	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ASAH1—intracranial aneurysm	0.000309	0.000657	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS3—intracranial aneurysm	0.000286	0.000608	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—intracranial aneurysm	0.00027	0.000573	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—intracranial aneurysm	0.000264	0.00056	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—intracranial aneurysm	0.00024	0.000509	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—intracranial aneurysm	0.000218	0.000464	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—intracranial aneurysm	0.000209	0.000445	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—intracranial aneurysm	0.000192	0.000408	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—intracranial aneurysm	0.000182	0.000386	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—intracranial aneurysm	0.000173	0.000368	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—intracranial aneurysm	0.000162	0.000344	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—intracranial aneurysm	0.000151	0.00032	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—intracranial aneurysm	0.000136	0.000288	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—intracranial aneurysm	0.000129	0.000274	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—intracranial aneurysm	0.000119	0.000254	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—intracranial aneurysm	7.37e-05	0.000157	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—intracranial aneurysm	6.46e-05	0.000137	CbGpPWpGaD
